Review



alkaline phosphatase ap conjugated anti mouse igg  (Toyobo)


Bioz Verified Symbol Toyobo is a verified supplier
Bioz Manufacturer Symbol Toyobo manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 94

    Structured Review

    Toyobo alkaline phosphatase ap conjugated anti mouse igg
    Alkaline Phosphatase Ap Conjugated Anti Mouse Igg, supplied by Toyobo, used in various techniques. Bioz Stars score: 94/100, based on 201 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/lpp/Alkaline+phosphatase/10__1016_slash_j__aqrep__2026__103811-67-15-28
    Average 94 stars, based on 201 article reviews
    alkaline phosphatase ap conjugated anti mouse igg - by Bioz Stars, 2026-11
    94/100 stars

    Images

    Related Articles

    Conjugation Assay:

    Article Title: Cardiac Troponin I Determination by an ELISA on Magnetic Particles with Electrochemical Detection
    Article Snippet: A highly sensitive method for the quantitative rapid determination of cardiac troponin I (cTnI) in human serum is developed.. The method is based on an enzyme-linked immunosorbent assay (ELISA) on magnetic particles in the volume of a blood serum sample, which can significantly reduce the diffusion limitations typical for the traditional ELISA.. Alkaline phosphatase which is a high-performance enzyme was used as an enzyme label.

    Modification:

    Article Title: Cardiac Troponin I Determination by an ELISA on Magnetic Particles with Electrochemical Detection
    Article Snippet: A highly sensitive method for the quantitative rapid determination of cardiac troponin I (cTnI) in human serum is developed.. The method is based on an enzyme-linked immunosorbent assay (ELISA) on magnetic particles in the volume of a blood serum sample, which can significantly reduce the diffusion limitations typical for the traditional ELISA.. Alkaline phosphatase which is a high-performance enzyme was used as an enzyme label.

    Expressing:

    Article Title: Designing monomeric IFNγ: The significance of domain-swapped dimer structure in IFNγ immune responses
    Article Snippet: The synthetic gene for a GS linker (NSNGGGGSGGGGSGGNSN) with a Bsp T104 I recognition sequence at its termini was purchased from Eurofins Japan. .. The GS linker synthetic gene and the WT expression vector were treated with Bsp T104 I and dephosphorylated using alkaline phosphatase (Toyobo Co, Ltd). .. The dephosphorylated genes were mixed, and ligation was performed using a ligation-convenience kit (Nippon Gene Co, Ltd).

    Article Title: Designing monomeric IFNγ: the significance of domain-swapped dimer structure in IFNγ immune responses.
    Article Snippet: The synthetic gene for a GS linker (NSNGGGGSGGGGSGGNSN) with a BspT104 I recognition sequence at its termini was purchased from Eurofins Japan (Tokyo, Japan). .. The GS linker synthetic gene and the WT expression vector were treated with BspT104 I and dephosphorylated using alkaline phosphatase (Toyobo Co., Ltd., Osaka, Japan). .. The dephosphorylated genes were mixed, and ligation was performed using a Ligation-Convenience Kit (Nippon Gene Co., Ltd., Toyama, Japan).

    Plasmid Preparation:

    Article Title: Designing monomeric IFNγ: The significance of domain-swapped dimer structure in IFNγ immune responses
    Article Snippet: The synthetic gene for a GS linker (NSNGGGGSGGGGSGGNSN) with a Bsp T104 I recognition sequence at its termini was purchased from Eurofins Japan. .. The GS linker synthetic gene and the WT expression vector were treated with Bsp T104 I and dephosphorylated using alkaline phosphatase (Toyobo Co, Ltd). .. The dephosphorylated genes were mixed, and ligation was performed using a ligation-convenience kit (Nippon Gene Co, Ltd).

    Article Title: Designing monomeric IFNγ: the significance of domain-swapped dimer structure in IFNγ immune responses.
    Article Snippet: The synthetic gene for a GS linker (NSNGGGGSGGGGSGGNSN) with a BspT104 I recognition sequence at its termini was purchased from Eurofins Japan (Tokyo, Japan). .. The GS linker synthetic gene and the WT expression vector were treated with BspT104 I and dephosphorylated using alkaline phosphatase (Toyobo Co., Ltd., Osaka, Japan). .. The dephosphorylated genes were mixed, and ligation was performed using a Ligation-Convenience Kit (Nippon Gene Co., Ltd., Toyama, Japan).

    In Vitro:

    Article Title:
    Article Snippet: .. An in vitro phosphatase assay was performed with 95 Escherichia coli alkaline phosphatase (BAP) from Toyobo. ..

    Phosphatase Assay:

    Article Title:
    Article Snippet: .. An in vitro phosphatase assay was performed with 95 Escherichia coli alkaline phosphatase (BAP) from Toyobo. ..

    Membrane:

    Article Title: Dietary defatted silkworm pupae modulate humoral and inflammatory immune responses following vaccination with formalin-killed Vibrio anguillarum in yellowtail (Seriola quinqueradiata)
    Article Snippet: The membrane was then incubated overnight at 4 °C with antiYT-IgM IgG diluted 1:5000 in immunoreaction enhancer solution (Can Get Signal Solution B, Toyobo, Tokyo, Japan). .. After washing with TTBS, the membrane was incubated for 1 h at room temperature with alkaline phosphatase (AP)-conjugated anti-mouse IgG diluted 1:2000 in Can Get Signal Solution A (Toyobo). .. Following additional washes, immunoreactive bands were detected using CDP-Star chemiluminescent substrate (Cytiva, Marlborough, MA, USA) with a chemiluminescence camera (ImageQuant LAS 4000, Cytiva), according to the manufacturer’s instructions.

    Incubation:

    Article Title: Dietary defatted silkworm pupae modulate humoral and inflammatory immune responses following vaccination with formalin-killed Vibrio anguillarum in yellowtail (Seriola quinqueradiata)
    Article Snippet: The membrane was then incubated overnight at 4 °C with antiYT-IgM IgG diluted 1:5000 in immunoreaction enhancer solution (Can Get Signal Solution B, Toyobo, Tokyo, Japan). .. After washing with TTBS, the membrane was incubated for 1 h at room temperature with alkaline phosphatase (AP)-conjugated anti-mouse IgG diluted 1:2000 in Can Get Signal Solution A (Toyobo). .. Following additional washes, immunoreactive bands were detected using CDP-Star chemiluminescent substrate (Cytiva, Marlborough, MA, USA) with a chemiluminescence camera (ImageQuant LAS 4000, Cytiva), according to the manufacturer’s instructions.



    Similar Products

    94
    Toyobo alkaline phosphatase ap conjugated anti mouse igg
    Alkaline Phosphatase Ap Conjugated Anti Mouse Igg, supplied by Toyobo, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/lpp/Alkaline+phosphatase/10__1016_slash_j__aqrep__2026__103811-67-15-28
    Average 94 stars, based on 1 article reviews
    alkaline phosphatase ap conjugated anti mouse igg - by Bioz Stars, 2026-11
    94/100 stars
      Buy from Supplier

    99
    New England Biolabs λ protein phosphatase lpp
    (A) After standard ARE pulldowns, the AR-DNA-bound complexes were washed and resuspended in 1x kinase buffer with/without ATP at 30 o C for listed times. Gel mobility shifts in AR were detected as a function of ATP addition. All pulldowns had 100 nM R1881 present. Proteins were analyzed by immunoblotting. Lanes 3 and 4 represent the standard AR-ARE pulldown. (B) To test if the above AR gel mobility shifts were reflective of phosphorylation events, the AR-CoR complexes were treated with ATP or AMP-PNP (non-hydrolyzable analogue) for 30 min at 30 o C. The DNA-PK inhibitor NU7441 or <t>λ</t> <t>protein</t> <t>phosphatase</t> <t>(LPP)</t> were pre-incubated for 5 min before adding ATP. LPP buffer was used for the LPP control reaction. (C) DNA-PK plays a role in phosphorylating AR. ATP treatment of the AR-CoR complexes using HeLa NE where DNA-PKcs was immunodepleted reveals a reduction of AR gel mobility shifts ( left panel) with the loss of DNA-PK. Proteins were assayed by immunoblotting and the level of unphosphorylated AR was quantified by Image J after normalization to the loading control HDAC1 ( right panel). P-value here = 0.00011. (D) DNA-bound AR or ARv7 was incubated with purified heterotrimeric DNA-PK (i.e., DNA-PKcs and Ku70/80) and then treated (-/+) ATP (-/+) NU7441 to demonstrate direct phosphorylation of AR/ARv7 by DNA-PK. Gel mobility shifts were assayed by immunoblotting. (E) ATP treatment (-/+) NU7441 pre-treatment demonstrates that DNA-PK enzymatic activity is needed for stabilizing CAND1 and ANP32A in the AR/ARv7 complexes. Auto-phosphorylation of DNA-PKcs at serine 2056 (pS2056) is a marker of DNA-PK activity and its inhibition by NU7441. Proteins were assayed by immunoblotting. ARv7 was detected here with the N-20 antibody. (F) HeLa NE used in 3xARE-E4 cell-free transcription assays was pre-treated (-/+) NU7441 to determine effects on AR and ARv7 transcriptional activity. E4 mRNA transcript levels were measured by RT-qPCR. In panels A-C and E, HDAC1 was used as a loading control and ARE pulldowns were conducted using HeLa NE as listed. All AR reactions had 100 nM R1881 present. Short exp., Medium exp., and Long exp. denote short, medium, and long exposures during x-ray film development. P-values: for ARv7, p = 0.00015; for AR, p = 0.000035. **** p < 0.0005, ***** p < 0.0001.
    λ Protein Phosphatase Lpp, supplied by New England Biolabs, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/lpp/Lambda+Protein+Phosphatase/pmc13175348-42-8-15
    Average 99 stars, based on 1 article reviews
    λ protein phosphatase lpp - by Bioz Stars, 2026-11
    99/100 stars
      Buy from Supplier

    94
    Proteintech antibodies against lpp
    (A) After standard ARE pulldowns, the AR-DNA-bound complexes were washed and resuspended in 1x kinase buffer with/without ATP at 30 o C for listed times. Gel mobility shifts in AR were detected as a function of ATP addition. All pulldowns had 100 nM R1881 present. Proteins were analyzed by immunoblotting. Lanes 3 and 4 represent the standard AR-ARE pulldown. (B) To test if the above AR gel mobility shifts were reflective of phosphorylation events, the AR-CoR complexes were treated with ATP or AMP-PNP (non-hydrolyzable analogue) for 30 min at 30 o C. The DNA-PK inhibitor NU7441 or <t>λ</t> <t>protein</t> <t>phosphatase</t> <t>(LPP)</t> were pre-incubated for 5 min before adding ATP. LPP buffer was used for the LPP control reaction. (C) DNA-PK plays a role in phosphorylating AR. ATP treatment of the AR-CoR complexes using HeLa NE where DNA-PKcs was immunodepleted reveals a reduction of AR gel mobility shifts ( left panel) with the loss of DNA-PK. Proteins were assayed by immunoblotting and the level of unphosphorylated AR was quantified by Image J after normalization to the loading control HDAC1 ( right panel). P-value here = 0.00011. (D) DNA-bound AR or ARv7 was incubated with purified heterotrimeric DNA-PK (i.e., DNA-PKcs and Ku70/80) and then treated (-/+) ATP (-/+) NU7441 to demonstrate direct phosphorylation of AR/ARv7 by DNA-PK. Gel mobility shifts were assayed by immunoblotting. (E) ATP treatment (-/+) NU7441 pre-treatment demonstrates that DNA-PK enzymatic activity is needed for stabilizing CAND1 and ANP32A in the AR/ARv7 complexes. Auto-phosphorylation of DNA-PKcs at serine 2056 (pS2056) is a marker of DNA-PK activity and its inhibition by NU7441. Proteins were assayed by immunoblotting. ARv7 was detected here with the N-20 antibody. (F) HeLa NE used in 3xARE-E4 cell-free transcription assays was pre-treated (-/+) NU7441 to determine effects on AR and ARv7 transcriptional activity. E4 mRNA transcript levels were measured by RT-qPCR. In panels A-C and E, HDAC1 was used as a loading control and ARE pulldowns were conducted using HeLa NE as listed. All AR reactions had 100 nM R1881 present. Short exp., Medium exp., and Long exp. denote short, medium, and long exposures during x-ray film development. P-values: for ARv7, p = 0.00015; for AR, p = 0.000035. **** p < 0.0005, ***** p < 0.0001.
    Antibodies Against Lpp, supplied by Proteintech, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/lpp/LPP+Antibody/pm41587621-187-0-10
    Average 94 stars, based on 1 article reviews
    antibodies against lpp - by Bioz Stars, 2026-11
    94/100 stars
      Buy from Supplier

    94
    Proteintech lpp antibody
    (A) After standard ARE pulldowns, the AR-DNA-bound complexes were washed and resuspended in 1x kinase buffer with/without ATP at 30 o C for listed times. Gel mobility shifts in AR were detected as a function of ATP addition. All pulldowns had 100 nM R1881 present. Proteins were analyzed by immunoblotting. Lanes 3 and 4 represent the standard AR-ARE pulldown. (B) To test if the above AR gel mobility shifts were reflective of phosphorylation events, the AR-CoR complexes were treated with ATP or AMP-PNP (non-hydrolyzable analogue) for 30 min at 30 o C. The DNA-PK inhibitor NU7441 or <t>λ</t> <t>protein</t> <t>phosphatase</t> <t>(LPP)</t> were pre-incubated for 5 min before adding ATP. LPP buffer was used for the LPP control reaction. (C) DNA-PK plays a role in phosphorylating AR. ATP treatment of the AR-CoR complexes using HeLa NE where DNA-PKcs was immunodepleted reveals a reduction of AR gel mobility shifts ( left panel) with the loss of DNA-PK. Proteins were assayed by immunoblotting and the level of unphosphorylated AR was quantified by Image J after normalization to the loading control HDAC1 ( right panel). P-value here = 0.00011. (D) DNA-bound AR or ARv7 was incubated with purified heterotrimeric DNA-PK (i.e., DNA-PKcs and Ku70/80) and then treated (-/+) ATP (-/+) NU7441 to demonstrate direct phosphorylation of AR/ARv7 by DNA-PK. Gel mobility shifts were assayed by immunoblotting. (E) ATP treatment (-/+) NU7441 pre-treatment demonstrates that DNA-PK enzymatic activity is needed for stabilizing CAND1 and ANP32A in the AR/ARv7 complexes. Auto-phosphorylation of DNA-PKcs at serine 2056 (pS2056) is a marker of DNA-PK activity and its inhibition by NU7441. Proteins were assayed by immunoblotting. ARv7 was detected here with the N-20 antibody. (F) HeLa NE used in 3xARE-E4 cell-free transcription assays was pre-treated (-/+) NU7441 to determine effects on AR and ARv7 transcriptional activity. E4 mRNA transcript levels were measured by RT-qPCR. In panels A-C and E, HDAC1 was used as a loading control and ARE pulldowns were conducted using HeLa NE as listed. All AR reactions had 100 nM R1881 present. Short exp., Medium exp., and Long exp. denote short, medium, and long exposures during x-ray film development. P-values: for ARv7, p = 0.00015; for AR, p = 0.000035. **** p < 0.0005, ***** p < 0.0001.
    Lpp Antibody, supplied by Proteintech, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/lpp/LPP+Antibody/pm41587621-222-36-40
    Average 94 stars, based on 1 article reviews
    lpp antibody - by Bioz Stars, 2026-11
    94/100 stars
      Buy from Supplier

    94
    Proteintech anti lpp
    (A) After standard ARE pulldowns, the AR-DNA-bound complexes were washed and resuspended in 1x kinase buffer with/without ATP at 30 o C for listed times. Gel mobility shifts in AR were detected as a function of ATP addition. All pulldowns had 100 nM R1881 present. Proteins were analyzed by immunoblotting. Lanes 3 and 4 represent the standard AR-ARE pulldown. (B) To test if the above AR gel mobility shifts were reflective of phosphorylation events, the AR-CoR complexes were treated with ATP or AMP-PNP (non-hydrolyzable analogue) for 30 min at 30 o C. The DNA-PK inhibitor NU7441 or <t>λ</t> <t>protein</t> <t>phosphatase</t> <t>(LPP)</t> were pre-incubated for 5 min before adding ATP. LPP buffer was used for the LPP control reaction. (C) DNA-PK plays a role in phosphorylating AR. ATP treatment of the AR-CoR complexes using HeLa NE where DNA-PKcs was immunodepleted reveals a reduction of AR gel mobility shifts ( left panel) with the loss of DNA-PK. Proteins were assayed by immunoblotting and the level of unphosphorylated AR was quantified by Image J after normalization to the loading control HDAC1 ( right panel). P-value here = 0.00011. (D) DNA-bound AR or ARv7 was incubated with purified heterotrimeric DNA-PK (i.e., DNA-PKcs and Ku70/80) and then treated (-/+) ATP (-/+) NU7441 to demonstrate direct phosphorylation of AR/ARv7 by DNA-PK. Gel mobility shifts were assayed by immunoblotting. (E) ATP treatment (-/+) NU7441 pre-treatment demonstrates that DNA-PK enzymatic activity is needed for stabilizing CAND1 and ANP32A in the AR/ARv7 complexes. Auto-phosphorylation of DNA-PKcs at serine 2056 (pS2056) is a marker of DNA-PK activity and its inhibition by NU7441. Proteins were assayed by immunoblotting. ARv7 was detected here with the N-20 antibody. (F) HeLa NE used in 3xARE-E4 cell-free transcription assays was pre-treated (-/+) NU7441 to determine effects on AR and ARv7 transcriptional activity. E4 mRNA transcript levels were measured by RT-qPCR. In panels A-C and E, HDAC1 was used as a loading control and ARE pulldowns were conducted using HeLa NE as listed. All AR reactions had 100 nM R1881 present. Short exp., Medium exp., and Long exp. denote short, medium, and long exposures during x-ray film development. P-values: for ARv7, p = 0.00015; for AR, p = 0.000035. **** p < 0.0005, ***** p < 0.0001.
    Anti Lpp, supplied by Proteintech, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/lpp/LPP+Antibody/pm41587621-205-31-32
    Average 94 stars, based on 1 article reviews
    anti lpp - by Bioz Stars, 2026-11
    94/100 stars
      Buy from Supplier

    94
    Toyobo alkaline phosphatase
    (A) After standard ARE pulldowns, the AR-DNA-bound complexes were washed and resuspended in 1x kinase buffer with/without ATP at 30 o C for listed times. Gel mobility shifts in AR were detected as a function of ATP addition. All pulldowns had 100 nM R1881 present. Proteins were analyzed by immunoblotting. Lanes 3 and 4 represent the standard AR-ARE pulldown. (B) To test if the above AR gel mobility shifts were reflective of phosphorylation events, the AR-CoR complexes were treated with ATP or AMP-PNP (non-hydrolyzable analogue) for 30 min at 30 o C. The DNA-PK inhibitor NU7441 or <t>λ</t> <t>protein</t> <t>phosphatase</t> <t>(LPP)</t> were pre-incubated for 5 min before adding ATP. LPP buffer was used for the LPP control reaction. (C) DNA-PK plays a role in phosphorylating AR. ATP treatment of the AR-CoR complexes using HeLa NE where DNA-PKcs was immunodepleted reveals a reduction of AR gel mobility shifts ( left panel) with the loss of DNA-PK. Proteins were assayed by immunoblotting and the level of unphosphorylated AR was quantified by Image J after normalization to the loading control HDAC1 ( right panel). P-value here = 0.00011. (D) DNA-bound AR or ARv7 was incubated with purified heterotrimeric DNA-PK (i.e., DNA-PKcs and Ku70/80) and then treated (-/+) ATP (-/+) NU7441 to demonstrate direct phosphorylation of AR/ARv7 by DNA-PK. Gel mobility shifts were assayed by immunoblotting. (E) ATP treatment (-/+) NU7441 pre-treatment demonstrates that DNA-PK enzymatic activity is needed for stabilizing CAND1 and ANP32A in the AR/ARv7 complexes. Auto-phosphorylation of DNA-PKcs at serine 2056 (pS2056) is a marker of DNA-PK activity and its inhibition by NU7441. Proteins were assayed by immunoblotting. ARv7 was detected here with the N-20 antibody. (F) HeLa NE used in 3xARE-E4 cell-free transcription assays was pre-treated (-/+) NU7441 to determine effects on AR and ARv7 transcriptional activity. E4 mRNA transcript levels were measured by RT-qPCR. In panels A-C and E, HDAC1 was used as a loading control and ARE pulldowns were conducted using HeLa NE as listed. All AR reactions had 100 nM R1881 present. Short exp., Medium exp., and Long exp. denote short, medium, and long exposures during x-ray film development. P-values: for ARv7, p = 0.00015; for AR, p = 0.000035. **** p < 0.0005, ***** p < 0.0001.
    Alkaline Phosphatase, supplied by Toyobo, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/lpp/Alkaline+phosphatase/pm41553656-79-7-9
    Average 94 stars, based on 1 article reviews
    alkaline phosphatase - by Bioz Stars, 2026-11
    94/100 stars
      Buy from Supplier

    94
    Toyobo alkaline phosphatase alp
    (A) After standard ARE pulldowns, the AR-DNA-bound complexes were washed and resuspended in 1x kinase buffer with/without ATP at 30 o C for listed times. Gel mobility shifts in AR were detected as a function of ATP addition. All pulldowns had 100 nM R1881 present. Proteins were analyzed by immunoblotting. Lanes 3 and 4 represent the standard AR-ARE pulldown. (B) To test if the above AR gel mobility shifts were reflective of phosphorylation events, the AR-CoR complexes were treated with ATP or AMP-PNP (non-hydrolyzable analogue) for 30 min at 30 o C. The DNA-PK inhibitor NU7441 or <t>λ</t> <t>protein</t> <t>phosphatase</t> <t>(LPP)</t> were pre-incubated for 5 min before adding ATP. LPP buffer was used for the LPP control reaction. (C) DNA-PK plays a role in phosphorylating AR. ATP treatment of the AR-CoR complexes using HeLa NE where DNA-PKcs was immunodepleted reveals a reduction of AR gel mobility shifts ( left panel) with the loss of DNA-PK. Proteins were assayed by immunoblotting and the level of unphosphorylated AR was quantified by Image J after normalization to the loading control HDAC1 ( right panel). P-value here = 0.00011. (D) DNA-bound AR or ARv7 was incubated with purified heterotrimeric DNA-PK (i.e., DNA-PKcs and Ku70/80) and then treated (-/+) ATP (-/+) NU7441 to demonstrate direct phosphorylation of AR/ARv7 by DNA-PK. Gel mobility shifts were assayed by immunoblotting. (E) ATP treatment (-/+) NU7441 pre-treatment demonstrates that DNA-PK enzymatic activity is needed for stabilizing CAND1 and ANP32A in the AR/ARv7 complexes. Auto-phosphorylation of DNA-PKcs at serine 2056 (pS2056) is a marker of DNA-PK activity and its inhibition by NU7441. Proteins were assayed by immunoblotting. ARv7 was detected here with the N-20 antibody. (F) HeLa NE used in 3xARE-E4 cell-free transcription assays was pre-treated (-/+) NU7441 to determine effects on AR and ARv7 transcriptional activity. E4 mRNA transcript levels were measured by RT-qPCR. In panels A-C and E, HDAC1 was used as a loading control and ARE pulldowns were conducted using HeLa NE as listed. All AR reactions had 100 nM R1881 present. Short exp., Medium exp., and Long exp. denote short, medium, and long exposures during x-ray film development. P-values: for ARv7, p = 0.00015; for AR, p = 0.000035. **** p < 0.0005, ***** p < 0.0001.
    Alkaline Phosphatase Alp, supplied by Toyobo, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/lpp/Alkaline+phosphatase/pm41576580-68-7-14
    Average 94 stars, based on 1 article reviews
    alkaline phosphatase alp - by Bioz Stars, 2026-11
    94/100 stars
      Buy from Supplier

    99
    New England Biolabs lpp
    a) xAM images of UReKA1 and UReKA2 incubated with PKA at various timepoints at 634kPa (for maximal signal). b) Normalized nonlinear US signal of UReKA1 (blue) and UReKA2 (orange) over time (n=3). c) Normalized phosphorylated fraction of UReKA1 (blue) and UReKA2 (orange) over time (n=1). d) Nonlinear ultrasound images (left) and signal (right) of UReKA1 incubated with PKA and phosphorylated UReKA1 incubated with <t>LPP</t> with or without buoyancy purification. (n=2). e-f) Schematics of the proposed molecular mechanism of UReKA with reversible phosphorylation reaction for the phosphorylation as forward reaction (e) <t>and</t> <t>dephosphorylation</t> of GvpC as reverse reaction (f).
    Lpp, supplied by New England Biolabs, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/lpp/Lambda+Protein+Phosphatase/bio_rxiv__64898__2025__11__30__691048-131-6-8
    Average 99 stars, based on 1 article reviews
    lpp - by Bioz Stars, 2026-11
    99/100 stars
      Buy from Supplier

    86
    Beijing Genomics Institute Shenzhen mlpa
    a) xAM images of UReKA1 and UReKA2 incubated with PKA at various timepoints at 634kPa (for maximal signal). b) Normalized nonlinear US signal of UReKA1 (blue) and UReKA2 (orange) over time (n=3). c) Normalized phosphorylated fraction of UReKA1 (blue) and UReKA2 (orange) over time (n=1). d) Nonlinear ultrasound images (left) and signal (right) of UReKA1 incubated with PKA and phosphorylated UReKA1 incubated with <t>LPP</t> with or without buoyancy purification. (n=2). e-f) Schematics of the proposed molecular mechanism of UReKA with reversible phosphorylation reaction for the phosphorylation as forward reaction (e) <t>and</t> <t>dephosphorylation</t> of GvpC as reverse reaction (f).
    Mlpa, supplied by Beijing Genomics Institute Shenzhen, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/lpp/mlpa/med_rxiv__2025__10__24__25338696-37-5-13
    Average 86 stars, based on 1 article reviews
    mlpa - by Bioz Stars, 2026-11
    86/100 stars
      Buy from Supplier

    86
    Radboud University multiplex ligation dependent probe amplification mlpa
    a) xAM images of UReKA1 and UReKA2 incubated with PKA at various timepoints at 634kPa (for maximal signal). b) Normalized nonlinear US signal of UReKA1 (blue) and UReKA2 (orange) over time (n=3). c) Normalized phosphorylated fraction of UReKA1 (blue) and UReKA2 (orange) over time (n=1). d) Nonlinear ultrasound images (left) and signal (right) of UReKA1 incubated with PKA and phosphorylated UReKA1 incubated with <t>LPP</t> with or without buoyancy purification. (n=2). e-f) Schematics of the proposed molecular mechanism of UReKA with reversible phosphorylation reaction for the phosphorylation as forward reaction (e) <t>and</t> <t>dephosphorylation</t> of GvpC as reverse reaction (f).
    Multiplex Ligation Dependent Probe Amplification Mlpa, supplied by Radboud University, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/lpp/amplification+dependent+ligation+mlpa+multiplex+probe/pm41134091-39-26-17
    Average 86 stars, based on 1 article reviews
    multiplex ligation dependent probe amplification mlpa - by Bioz Stars, 2026-11
    86/100 stars
      Buy from Supplier

    Image Search Results


    (A) After standard ARE pulldowns, the AR-DNA-bound complexes were washed and resuspended in 1x kinase buffer with/without ATP at 30 o C for listed times. Gel mobility shifts in AR were detected as a function of ATP addition. All pulldowns had 100 nM R1881 present. Proteins were analyzed by immunoblotting. Lanes 3 and 4 represent the standard AR-ARE pulldown. (B) To test if the above AR gel mobility shifts were reflective of phosphorylation events, the AR-CoR complexes were treated with ATP or AMP-PNP (non-hydrolyzable analogue) for 30 min at 30 o C. The DNA-PK inhibitor NU7441 or λ protein phosphatase (LPP) were pre-incubated for 5 min before adding ATP. LPP buffer was used for the LPP control reaction. (C) DNA-PK plays a role in phosphorylating AR. ATP treatment of the AR-CoR complexes using HeLa NE where DNA-PKcs was immunodepleted reveals a reduction of AR gel mobility shifts ( left panel) with the loss of DNA-PK. Proteins were assayed by immunoblotting and the level of unphosphorylated AR was quantified by Image J after normalization to the loading control HDAC1 ( right panel). P-value here = 0.00011. (D) DNA-bound AR or ARv7 was incubated with purified heterotrimeric DNA-PK (i.e., DNA-PKcs and Ku70/80) and then treated (-/+) ATP (-/+) NU7441 to demonstrate direct phosphorylation of AR/ARv7 by DNA-PK. Gel mobility shifts were assayed by immunoblotting. (E) ATP treatment (-/+) NU7441 pre-treatment demonstrates that DNA-PK enzymatic activity is needed for stabilizing CAND1 and ANP32A in the AR/ARv7 complexes. Auto-phosphorylation of DNA-PKcs at serine 2056 (pS2056) is a marker of DNA-PK activity and its inhibition by NU7441. Proteins were assayed by immunoblotting. ARv7 was detected here with the N-20 antibody. (F) HeLa NE used in 3xARE-E4 cell-free transcription assays was pre-treated (-/+) NU7441 to determine effects on AR and ARv7 transcriptional activity. E4 mRNA transcript levels were measured by RT-qPCR. In panels A-C and E, HDAC1 was used as a loading control and ARE pulldowns were conducted using HeLa NE as listed. All AR reactions had 100 nM R1881 present. Short exp., Medium exp., and Long exp. denote short, medium, and long exposures during x-ray film development. P-values: for ARv7, p = 0.00015; for AR, p = 0.000035. **** p < 0.0005, ***** p < 0.0001.

    Journal: PLOS One

    Article Title: Identification of CAND1 as a DNA-dependent protein kinase-regulated coactivator of androgen receptor and the ARv7 splice variant

    doi: 10.1371/journal.pone.0349130

    Figure Lengend Snippet: (A) After standard ARE pulldowns, the AR-DNA-bound complexes were washed and resuspended in 1x kinase buffer with/without ATP at 30 o C for listed times. Gel mobility shifts in AR were detected as a function of ATP addition. All pulldowns had 100 nM R1881 present. Proteins were analyzed by immunoblotting. Lanes 3 and 4 represent the standard AR-ARE pulldown. (B) To test if the above AR gel mobility shifts were reflective of phosphorylation events, the AR-CoR complexes were treated with ATP or AMP-PNP (non-hydrolyzable analogue) for 30 min at 30 o C. The DNA-PK inhibitor NU7441 or λ protein phosphatase (LPP) were pre-incubated for 5 min before adding ATP. LPP buffer was used for the LPP control reaction. (C) DNA-PK plays a role in phosphorylating AR. ATP treatment of the AR-CoR complexes using HeLa NE where DNA-PKcs was immunodepleted reveals a reduction of AR gel mobility shifts ( left panel) with the loss of DNA-PK. Proteins were assayed by immunoblotting and the level of unphosphorylated AR was quantified by Image J after normalization to the loading control HDAC1 ( right panel). P-value here = 0.00011. (D) DNA-bound AR or ARv7 was incubated with purified heterotrimeric DNA-PK (i.e., DNA-PKcs and Ku70/80) and then treated (-/+) ATP (-/+) NU7441 to demonstrate direct phosphorylation of AR/ARv7 by DNA-PK. Gel mobility shifts were assayed by immunoblotting. (E) ATP treatment (-/+) NU7441 pre-treatment demonstrates that DNA-PK enzymatic activity is needed for stabilizing CAND1 and ANP32A in the AR/ARv7 complexes. Auto-phosphorylation of DNA-PKcs at serine 2056 (pS2056) is a marker of DNA-PK activity and its inhibition by NU7441. Proteins were assayed by immunoblotting. ARv7 was detected here with the N-20 antibody. (F) HeLa NE used in 3xARE-E4 cell-free transcription assays was pre-treated (-/+) NU7441 to determine effects on AR and ARv7 transcriptional activity. E4 mRNA transcript levels were measured by RT-qPCR. In panels A-C and E, HDAC1 was used as a loading control and ARE pulldowns were conducted using HeLa NE as listed. All AR reactions had 100 nM R1881 present. Short exp., Medium exp., and Long exp. denote short, medium, and long exposures during x-ray film development. P-values: for ARv7, p = 0.00015; for AR, p = 0.000035. **** p < 0.0005, ***** p < 0.0001.

    Article Snippet: DNA-PK inhibitor NU7441 was purchased from Tocris Bioscience. λ protein phosphatase (LPP) was purchased from New England Biolabs.

    Techniques: Western Blot, Phospho-proteomics, Incubation, Control, Purification, Activity Assay, Marker, Inhibition, Quantitative RT-PCR

    a) xAM images of UReKA1 and UReKA2 incubated with PKA at various timepoints at 634kPa (for maximal signal). b) Normalized nonlinear US signal of UReKA1 (blue) and UReKA2 (orange) over time (n=3). c) Normalized phosphorylated fraction of UReKA1 (blue) and UReKA2 (orange) over time (n=1). d) Nonlinear ultrasound images (left) and signal (right) of UReKA1 incubated with PKA and phosphorylated UReKA1 incubated with LPP with or without buoyancy purification. (n=2). e-f) Schematics of the proposed molecular mechanism of UReKA with reversible phosphorylation reaction for the phosphorylation as forward reaction (e) and dephosphorylation of GvpC as reverse reaction (f).

    Journal: bioRxiv

    Article Title: Ultrasonic Reporter of Kinase Activity

    doi: 10.64898/2025.11.30.691048

    Figure Lengend Snippet: a) xAM images of UReKA1 and UReKA2 incubated with PKA at various timepoints at 634kPa (for maximal signal). b) Normalized nonlinear US signal of UReKA1 (blue) and UReKA2 (orange) over time (n=3). c) Normalized phosphorylated fraction of UReKA1 (blue) and UReKA2 (orange) over time (n=1). d) Nonlinear ultrasound images (left) and signal (right) of UReKA1 incubated with PKA and phosphorylated UReKA1 incubated with LPP with or without buoyancy purification. (n=2). e-f) Schematics of the proposed molecular mechanism of UReKA with reversible phosphorylation reaction for the phosphorylation as forward reaction (e) and dephosphorylation of GvpC as reverse reaction (f).

    Article Snippet: For dephosphorylation assays, 10 units of LPP (P0753L; NEB) per μL of engineered GVs at OD500 = 10 were mixed with PMP Buffer (50 mM HEPES, 100 mM NaCl, 2 mM DTT, 0.01% Brij 35, pH 7.5) and 1 mM MnCl 2 , followed by incubation with slow rotation at 37°C for 10–12 hours.

    Techniques: Incubation, Purification, Phospho-proteomics, De-Phosphorylation Assay